The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded Scripps Research Institute, a nonprofit biomedical research organization, a $529,125 project grant to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder with the goal of discovering targeted therapies. This 3-year award, effective September 30, 2024, will fund research aimed at improving the health and care of military service members, veterans, and their families...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $824,505 Project Grant to the Sunnybrook Research Institute in Canada. The funding will support novel therapeutic and delivery strategies for primary auditory neuron regeneration research over a 3-year period from August 1, 2024 to July 31, 2027. The Sunnybrook Research Institute, a leading Canadian biomedical research center, will leverage its expertise in neuroscience,...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $451,000.00 to the University of Texas Southwestern Medical Center to conduct research on "DISSECTING BIOLOGICAL MECHANISMS UNDERLYING BEHAVIORAL HETEROGENEITY IN AUTISM" from April 1, 2024 to March 31, 2027. The research aims to advance scientific understanding of the biological basis for the variability in autism spectrum disorder symptoms and...
The Feinstein Institutes for Medical Research received a $921,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a study from August 15, 2022 to August 14, 2025 to research microglia as potential therapeutic targets for Autism Spectrum Disorder (ASD) using a mouse model of maternal anti-Caspr2 antibody-induced ASD. The Military Medical Research and Development program supports...
The Defense Health Agency awarded a $863,500 Project Grant to Rutgers, The State University of New Jersey under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning September 1, 2022 will support research into "Genetically Distinct ASD Subtypes: Is MTOR Dysregulation a Common Mechanism?" Through this funding, Rutgers researchers will investigate potential connections between mutations in the MTOR gene pathway and autism...
The University of California, San Diego will research the mechanisms of heterogeneous neural expression of autism spectrum disorder under a three-year, $868,542 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Assistance Listing Number 12.420. This program supports biomedical research that transforms military and public health care through innovative solutions for battlefield...
This $485,597.91 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research at the Universite De Sherbrooke in Canada. The award will fund a 3-year project from August 1, 2024 to July 31, 2027 focused on understanding the "CONTRIBUTION OF ALTERNATIVE SPLICING TO NEUROFIBROMAGENESIS." The research aims to advance scientific knowledge in the area of neurological disorders, which...
This $462,131 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports transformative behavioral health research to improve quality of life for individuals with childhood-onset lupus. The prime awardee, The Hospital for Sick Children (Sick Kids Hospital) in Toronto, Canada, will lead this 4-year initiative. As a leading pediatric research hospital, Sick Kids Hospital has extensive experience as a subcontractor on...
This federal Project Grant award for $321,981.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a research project titled "Sensory Processing Contributions to Emotion Dysregulation and Internalizing Problems in Autism" conducted by the University of California, Davis from April 1, 2025 to March 31, 2027. The research aims to investigate neural mechanisms and sensory processing factors that contribute...
The Defense Health Agency awarded a $697,766 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Murdoch Children's Research Institute in Australia. The grant, awarded on July 15, 2024, will fund a 3-year research project titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The project aims to conduct biomedical research to better understand and characterize brain development in children and adolescents with...